Selected publications
-
Phase I trials of anti-ENPP3 antibody–drug conjugates in advanced refractory renal cell carcinomas.
Clinical Cancer Research.
2018
Academic Article
GET IT
Times cited: 6 -
Safety and efficacy of nivolumab in patients with metastatic renal cell carcinoma treated beyond progression.
JAMA oncology.
2016
Academic Article
GET IT
Times cited: 86 -
Pilot trial of selecting molecularly guided therapy for patients with non-V600 BRAF-mutant metastatic melanoma: Experience of the SU2C/MRA melanoma dream team.
Molecular Cancer Therapeutics.
2015
Academic Article
GET IT
Times cited: 16 -
Testicular cancer, version 2.2015: Clinical pactice guidelines in oncology.
JNCCN Journal of the National Comprehensive Cancer Network.
2015
Academic Article
GET IT
Times cited: 63 -
Nivolumab for metastatic renal cell carcinoma: Results of a randomized phase II trial.
Journal of Clinical Oncology.
2015
Academic Article
GET IT
Times cited: 564 -
Kidney cancer, version 3.2015: Featured updates to the NCCN guidelines.
JNCCN Journal of the National Comprehensive Cancer Network.
2015
Review
GET IT
Times cited: 158 -
Kidney cancer, version 2.2014.
JNCCN Journal of the National Comprehensive Cancer Network.
2014
Review
GET IT
Times cited: 44 -
Testicular cancer.
JNCCN Journal of the National Comprehensive Cancer Network.
2012
Review
GET IT
Times cited: 51 -
Kidney cancer.
JNCCN Journal of the National Comprehensive Cancer Network.
2011
Review
GET IT
Times cited: 66 -
Phase I/II trial of sunitinib plus gefitinib in patients with metastatic renal cell carcinoma.
American Journal of Clinical Oncology: Cancer Clinical Trials.
2010
Academic Article
GET IT
Times cited: 25 -
Kidney cancer.
JNCCN Journal of the National Comprehensive Cancer Network.
2009
Review
GET IT
Times cited: 145 -
Testicular cancer.
JNCCN Journal of the National Comprehensive Cancer Network.
2009
Review
GET IT
Times cited: 80 -
Sunitinib Efficacy Against Advanced Renal Cell Carcinoma.
Journal of Urology.
2007
Academic Article
GET IT
Times cited: 174 -
Kidney cancer clinical practice guidelines in oncology.
JNCCN Journal of the National Comprehensive Cancer Network.
2006
Review
GET IT
Times cited: 6 -
Testicular cancer clinical practice guidelines in oncology.
JNCCN Journal of the National Comprehensive Cancer Network.
2006
Review
GET IT
Times cited: 16 -
Sunitinib in patients with metastatic renal cell carcinoma.
JAMA - Journal of the American Medical Association.
2006
Academic Article
GET IT
Times cited: 1039 -
Activity of SU11248, a multitargeted inhibitor of vascular endothelial growth factor receptor and platelet-derived growth factor receptor, in patients with metastatic renal cell carcinoma.
Journal of Clinical Oncology.
2006
Academic Article
GET IT
Times cited: 1433 -
Kidney cancer: Clinical practice guidelines.
JNCCN Journal of the National Comprehensive Cancer Network.
2005
Review
GET IT
Times cited: 1 -
Testicular cancer: Clinical practice guidelines.
JNCCN Journal of the National Comprehensive Cancer Network.
2005
Review
GET IT
Times cited: 4 -
Southwest Oncology Group study of paclitaxel and carboplatin for advanced transitional-cell carcinoma: The importance of survival as a clinical trial end point.
Journal of Clinical Oncology.
2000
Academic Article
GET IT
Times cited: 93